Active specific immunotherapy for human colon cancer: a prospectively randomized trial in stage II and II disease

J.B. Vermorken; A.M.E. Claessen; H. van Tinteren; H.E. Gall; R.M.R. Ezinga; S. Meijer; R.J. Scheper; C.J.L.M. Meijer; E. Bloemena; J.H. Ransom; M.G. Hanna; H.M. Pinedo

doi:10.1016/S0140-6736(98)07186-4

Active specific immunotherapy for human colon cancer: a prospectively randomized trial in stage II and II disease

J.B. Vermorken, A.M.E. Claessen, H. van Tinteren, H.E. Gall, R.M.R. Ezinga, S. Meijer, R.J. Scheper, C.J.L.M. Meijer, E. Bloemena, J.H. Ransom, M.G. Hanna, H.M. Pinedo

VU University medical center

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	345-350
Journal	Lancet
Volume	353
DOIs	https://doi.org/10.1016/S0140-6736(98)07186-4
Publication status	Published - 1999

Access to Document

10.1016/S0140-6736(98)07186-4

Embargoed Document

126614
Final published version, 79.4 KB

Cite this

Vermorken, J. B., Claessen, A. M. E., van Tinteren, H., Gall, H. E., Ezinga, R. M. R., Meijer, S., Scheper, R. J., Meijer, C. J. L. M., Bloemena, E., Ransom, J. H., Hanna, M. G., & Pinedo, H. M. (1999). Active specific immunotherapy for human colon cancer: a prospectively randomized trial in stage II and II disease. Lancet, 353, 345-350. https://doi.org/10.1016/S0140-6736(98)07186-4

@article{8846f3b6fad148e9aaba86a380519e88,

title = "Active specific immunotherapy for human colon cancer: a prospectively randomized trial in stage II and II disease",

author = "J.B. Vermorken and A.M.E. Claessen and {van Tinteren}, H. and H.E. Gall and R.M.R. Ezinga and S. Meijer and R.J. Scheper and C.J.L.M. Meijer and E. Bloemena and J.H. Ransom and M.G. Hanna and H.M. Pinedo",

year = "1999",

doi = "10.1016/S0140-6736(98)07186-4",

language = "English",

volume = "353",

pages = "345--350",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Active specific immunotherapy for human colon cancer: a prospectively randomized trial in stage II and II disease

AU - Vermorken, J.B.

AU - Claessen, A.M.E.

AU - van Tinteren, H.

AU - Gall, H.E.

AU - Ezinga, R.M.R.

AU - Meijer, S.

AU - Scheper, R.J.

AU - Meijer, C.J.L.M.

AU - Bloemena, E.

AU - Ransom, J.H.

AU - Hanna, M.G.

AU - Pinedo, H.M.

PY - 1999

Y1 - 1999

U2 - 10.1016/S0140-6736(98)07186-4

DO - 10.1016/S0140-6736(98)07186-4

M3 - Article

VL - 353

SP - 345

EP - 350

JO - Lancet

JF - Lancet

SN - 0140-6736

ER -